Source comparison
How Long Does MK-677 Take to Work in Research: Comparison
Serum IGF-1 Elevation 24–48 hours Direct GH secretion → hepatic IGF-1 synthesis 4–6 weeks (plateau) Earliest biomarker. Not the outcome itself Growth Hormone Pulsatility Within 2–3 hours post-dose GHS-R1a activation in pituitary Acute response each dose Useful
This comparison does not assign a generated winner or score.
- Serum IGF-1 Elevation
- 24–48 hours
- Direct GH secretion → hepatic IGF-1 synthesis
- 4–6 weeks (plateau)
- Earliest biomarker. Not the outcome itself
- Growth Hormone Pulsatility
- Within 2–3 hours post-dose
- GHS-R1a activation in pituitary
- Acute response each dose
- Useful for verifying compound activity
- Lean Body Mass Increase
- 8–12 weeks
- Sustained mTOR activation + protein synthesis upregulation
- 12–16 weeks
- Requires consistent dosing + adequate protein intake (1.6–2.2g/kg)
- Bone Mineral Density
- 16–24 weeks
- Osteoblast activity + bone remodeling cycle duration
- 12+ months
- Long-timeline endpoint. Not suitable for short studies
- Fat Mass Reduction
- Lipolysis upregulation via GH + improved insulin sensitivity (late adaptation)
- Modest effect. Not primary mechanism
- Sleep Quality (REM duration)
- 1–2 weeks
- Mechanism unclear. Possibly ghrelin receptor CNS effects
- 4–6 weeks
- Highly variable between subjects